Evaluation of Corrected QT Intervals of 74 COVID19 Patients Treated with Hydroxychloroquine in Combination with or without Azithromycin and/or Favipiravir

UYAROĞLU, OĞUZ; ŞENER, YUSUF; ÖZDEDE, MURAT; ÇALIK BAŞARAN, NURSEL; ÖZIŞIK, LALE; ŞAHİN, TAHA; CANPOLAT, UĞUR; İNKAYA, AHMET; YORGUN, HİKMET; SAİN GÜVEN, GÜLAY; AYTEMİR, KUDRET

doi:10.5152/eurjther.2021.21022

Evaluation of Corrected QT Intervals of 74 COVID19 Patients Treated with Hydroxychloroquine in Combination with or without Azithromycin and/or Favipiravir

Copy For Citation

UYAROĞLU O. A., ŞENER Y. Z., ÖZDEDE M., ÇALIK BAŞARAN N., ÖZIŞIK L., ŞAHİN T. K., ...More

European Journal of Therapeutics, vol.27, no.4, pp.311-317, 2021 (ESCI)

Publication Type: Article / Article
Volume: 27 Issue: 4
Publication Date: 2021
Doi Number: 10.5152/eurjther.2021.21022
Journal Name: European Journal of Therapeutics
Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Page Numbers: pp.311-317
Keywords: COVID-19, corrected QT, hydroxychloroquine, azithromycin, favipiravir, RISK
Hacettepe University Affiliated: Yes

Abstract

Objective: We aimed to evaluate the degree of QTc prolongation and associated factors in patients with COVID-19 in association with their usage of hydroxychloroquine (HCQ) with or without the combination of azithromycin (AZ) and/or favipiravir (FAV).